Kontos MC, de Lemos JA, Deitelzweig SB, et al. 2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;80(20):1925-1960.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289-1367.
Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. Circulation. 2022;146:569-581.
Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368-e454.
McCarthy C, Li S, Wang TY, et al. Implementation of High-Sensitivity Cardiac Troponin Assays in the United States. J Am Coll Cardiol. 2023;81(3):207-219.
Yang HS, Shemesh A, Li J, et al. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay. Clin Biochem. 2021;89:77-80.
Khan E, Lambrakis K, Nazir SA, et al. Implementation of more sensitive cardiac troponin T assay in a state-wide health service. Int J Cardiol. 2022;347:66-72.
Peck D, Knott J, Lefkovits J. Clinical impact of a high-sensitivity troponin assay introduction on patients presenting to the emergency department. Emerg Med Australas. 2016;28:273-8.
Greenslade JH, Parsonage W, Foran L, et al. Widespread Introduction of a High-Sensitivity Troponin Assay: Assessing the Impact on Patients and Health Services. J Clin Med. 2020;9(6):1883.
Jülicher P, Greenslade JH, Parsonage WA, Cullen L. The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis. BMJ Open. 2017;7:e013653.
Roos A, Holzmann MJ. Healthcare and Resource Use in Patients With Stable High-Sensitivity Cardiac Troponin T Levels. Am J Cardiol. 2020;128:67-74.
Anand A, Lee KK, Chapman AR, et al. High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial. Circulation. 2021;143:2214-2224.
Ambavane A, Lindahl B, Giannitsis E, et al. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department. PLoS One. 2017;12:e0187662.
Conway R, Byrne D, Cournane S, O'Riordan D, Coveney S, Silke B. Is there excessive troponin testing in clinical practice? Evidence from emergency medical admissions. Eur J Intern Med. 2021;86:48-53.
Johannessen TR, Halvorsen S, Atar D, et al. Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting. BMC Health Serv Res. 2022;22:1274.
Ford JS, Chaco E, Tancredi DJ, Mumma BE. Impact of high-sensitivity cardiac troponin implementation on emergency department length of stay, testing, admissions, and diagnoses. Am J Emerg Med. 2021;45:54-60.
Suh EH, Tichter AM, Ranard LS, et al. Impact of a rapid high-sensitivity troponin pathway on patient flow in an urban emergency department. J Am Coll Emerg Physicians Open. 2022;3:e12739.
Bevins NJ, Chae H, Hubbard JA, et al. Emergency Department Management of Chest Pain With a High-Sensitivity Troponin-Enabled 0/1-Hour Rule-Out Algorithm. Am J Clin Pathol. 2022;157:774-780.
Ola O, Akula A, Michieli LD, et al. Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community. J Am Coll Cardiol. 2021;77:3160-3170.
Younis A, Farooq S, Bisognano JD, et al. Outcomes Associated with Introduction of the 5(th) Generation High-Sensitivity Cardiac Troponin in Patients Presenting with Cardiovascular Disorders. J Emerg Med. 2022;62:657-667.
Tomaszewski CA, Nestler D, Shah KH, Sudhir A, Brown MD. Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department Patients With Suspected Non-ST-Elevation Acute Coronary Syndromes. Ann Emerg Med. 2018;72:e65-e106.
Fischer BG, Evans AT. High-Sensitivity Cardiac Troponin Algorithms and the Value of Likelihood Ratios. J Gen Intern Med. 2023;38(9):2189-2193.
Rohrer JM. Thinking clearly about correlations and causation: Graphical causal models for observational data. Advances in Methods and Practices in Psychological Science. 2018;1:27-42.
Polubriaginof FCG, Ryan P, Salmasian H, et al. Challenges with quality of race and ethnicity data in observational databases. J Am Med Inform Assoc. 2019;26:730-736.
Chartier LB, Ovens H, Hayes E, et al. Improving Quality of Care Through a Mandatory Provincial Audit Program: Ontario's Emergency Department Return Visit Quality Program. Ann Emerg Med. 2021;77:193-202.
Rising KL, Karp DN, Powell RE, Victor TW, Carr BG. Geography, Not Health System Affiliations, Determines Patients' Revisits to the Emergency Department. Health Serv Res. 2018;53:1092-1109.
Shy BD, Loo GT, Lowry T, et al. Bouncing Back Elsewhere: Multilevel Analysis of Return Visits to the Same or a Different Hospital After Initial Emergency Department Presentation. Ann Emerg Med. 2018;71:555-563.e1.
Comments (0)